StockData

Generate Biomedicines, Inc. (GENB) stock

GENBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$9.84−0.65 (-6.20%)

Close on Nov 17, 2026Market cap $1.26BP/E –Yield –

Generate Biomedicines ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$87.81M–
Q2 FY2026Jun 30, 2026-$68.41M–
Q1 FY2026Mar 31, 2026-$60.84M–
Q3 FY2025Sep 30, 2025-$59.51M–
Q2 FY2025Jun 30, 2025-$56.85M–
Q1 FY2025Mar 31, 2025-$44.74M–

More Generate Biomedicines figures

See a number that looks wrong?